7TM Pharma A/S, Fremtidsvej 3, DK-2970 Hørsholm, Denmark.
Bioorg Med Chem Lett. 2010 Jan 1;20(1):26-30. doi: 10.1016/j.bmcl.2009.11.047. Epub 2009 Nov 15.
A chemically diverse library of secondary and tertiary 4-cyanomethyl-1,5-diphenyl-1H-pyrazole-3-carboxamides was synthesized to enable mapping of the SAR, in the eastern amide region, with regard to CB1 antagonist activity, This study was initiated as a prelude to the design and synthesis of possible CB1 antagonists that do not readily pass the blood-brain-barrier. In general a range of modifications were found to be tolerated in this part of the molecule, although polar and especially charged groups did to a degree reduce the CB1 antagonistic activity. Several compounds with single-digit or even sub-nanomolar potency, suitable for further elaboration of the nitrile moiety, were identified.
合成了一个结构多样的二级和三级 4-氰甲基-1,5-二苯基-1H-吡唑-3-甲酰胺文库,以绘制 SAR 图,研究东部酰胺区域的 CB1 拮抗剂活性。这项研究是设计和合成不易通过血脑屏障的可能 CB1 拮抗剂的序幕。通常,在分子的这一部分发现可以容忍一系列修饰,尽管极性特别是带电荷的基团在一定程度上降低了 CB1 拮抗活性。鉴定出几种具有个位数甚至亚纳摩尔效力的化合物,适合进一步修饰腈部分。